Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

Background: Studies have reported that advanced NSCLC benefits from celecoxib combined with systematic treatment. However, the optimal combination with different treatments remains unclear. A meta-analysis was conducted to explore treatment combinations. Methods: We searched the relevant literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Yi, Lilan, Shen, Jie, Zhang, Hongman, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052875/
https://www.ncbi.nlm.nih.gov/pubmed/32194793
http://dx.doi.org/10.7150/jca.35003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052875/
https://www.ncbi.nlm.nih.gov/pubmed/32194793
http://dx.doi.org/10.7150/jca.35003

Ejemplares similares